Earpiece Glucose Sensor Near-Infrared Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current glucose monitoring methods for diabetes patients are invasive and do not provide continuous monitoring, necessitating the development of non-invasive technologies that can effectively measure blood glucose levels.

Innovation Solution

Integration of a non-invasive near-infrared glucose sensor into an earpiece, which is positioned to detect glucose levels in the rich blood supply of the ear and ear canal, allowing for continuous monitoring and wireless communication of glucose data to a mobile device.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If invasive technologies are used for glucose detection, then accurate measurement of blood glucose levels is achieved, but user comfort and convenience deteriorate

Engineering Contradiction:
Improveglucose measurement accuracyVSAvoiduser comfort
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent replaces invasive mechanical blood sampling with a non-invasive optical sensing system. The glucose sensor uses near-infrared spectroscopy to detect glucose levels through the ear canal wall, eliminating the need for needles or blood draws while maintaining measurement capability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces an intermediary optical measurement approach by measuring glucose through the ear canal wall rather than directly in blood. This intermediary method allows indirect detection of glucose levels without breaking the skin or requiring direct blood contact.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If traditional glucose monitoring methods are used, then glucose levels can be measured, but continuous monitoring capability is lost

Engineering Contradiction:
Improveglucose level detectionVSAvoidmonitoring continuity
Core Design Contradiction:
Measurement precisionVSDuration of action of moving object

Solution Approach 1:

The patent enables continuous glucose monitoring by positioning the sensor in the ear canal for ongoing measurements. The sensor can continuously or periodically measure glucose levels through the ear canal wall, providing uninterrupted monitoring data compared to discrete traditional methods.

Inventive Principle:
Principle #20Continuity of useful action

3Ease of operation

If non-invasive glucose sensing is implemented, then user comfort is improved, but measurement precision may deteriorate

Engineering Contradiction:
Improvenon-invasive measurementVSAvoidblood glucose level accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent uses near-infrared optical spectroscopy to substitute for direct blood sampling. This optical method penetrates the ear canal wall to detect glucose-related molecular vibrations, providing non-invasive measurement while maintaining analytical precision through spectral analysis.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables continuous, non-invasive glucose monitoring, providing accurate and timely glucose level data to users, particularly those with diabetes, thereby aiding in maintaining healthy blood glucose levels.

Implementation Method 1

The glucose sensor may use near infrared sensors

Methodology Applied
Scientific EffectNear-infrared absorption: Absorption (EM radiation)

Data Source

PatentUS20210077025A1Earpiece with glucose sensor and system
Publication Date: 2021.03.18 BRAGI
  • US20210077025A1 patent drawing
  • US20210077025A1 patent drawing
  • US20210077025A1 patent drawing

AI summary

An earpiece may include an earpiece housing, an intelligent control disposed within the earpiece housing, and a glucose sensor operatively connected to the intelligent control. The intelligent control may be configured to determine glucose levels associated with a user of the earpiece using the glucose sensor. The earpiece may further include a wireless transceiver disposed within the earpiece housing, the wireless transceiver operatively connected to the intelligent control. The glucose sensor may be a non-invasive glucose sensor such as a near infrared glucose sensor. The earpiece housing may be configured to position the glucose sensor against a wall of the external auditory canal.